Le Lézard
Classified in: Health, Science and technology
Subjects: TDS, TRI

Myeloid Therapeutics to Provide Updates on its RNA Immunotherapies at Multiple Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2024


CAMBRIDGE, Mass., March 5, 2024 /PRNewswire/ -- Myeloid Therapeutics, Inc. ("Myeloid"), a clinical stage immunology company, today announced it will be providing updates on its RNA immunotherapies at multiple presentations at the American Association for Cancer Research (AACR) Annual Meeting taking place April 5-10, 2024, at the San Diego Convention Center.

Details follow:

Title: In vivo programming of natural killer cells and T cells using mRNA delivered cytotoxic chimeric antigen receptors
Date & Time: Monday Apr 8, 2024, 9:00 AM - 12:30 PM
Location: Poster Section 2
Session Category: Immunology
Session Title: CAR-NK, NK Engagers, and NK Modulators
Poster Board Number: 2
Published Abstract Number: 1319

Title: In vivo Immune Cell Programming Using mRNA-LNP Chimeric Antigen Receptors
Date & Time: Monday Apr 8, 2024, 9:00 AM - 12:30 PM
Location: Poster Section 2
Session Category: Immunology
Session Title: CAR-NK, NK Engagers, and NK Modulators
Poster Board Number: 4
Published Abstract Number: 1321

Title: Preclinical & clinical activity of autologous mRNA engineered chimeric antigen receptor monocytes for targeted cancer immunotherapy
Date & Time: Monday Apr 8, 2024, 1:30 PM - 5:00 PM
Location: Poster Section 39
Session Category: Clinical Research
Session Title: Adoptive Cellular Therapy 1
Poster Board Number: 18
Published Abstract Number: 3612

About Myeloid Therapeutics
Myeloid Therapeutics is a clinical stage immunology company, engineering cutting-edge RNA technology to program immune cells to combat cancer and other deadly diseases. Myeloid is headquartered in Cambridge, MA. For additional information, please visit, https://www.myeloidtx.com/ and follow us on LinkedIn and X/Twitter.

To meet with Myeloid leadership at AACR 2024 please email: [email protected]

Investor Contact
Amy Conrad
Juniper Point
[email protected]

Media Contact
Jennifer Hanley
Ridge Hill Group
[email protected]

(PRNewsfoto/Myeloid Therapeutics)

 

SOURCE Myeloid Therapeutics, Inc.


These press releases may also interest you

at 11:49
Philadelphia Jury Returns $10 Million Verdict Against Albert Einstein Medical Center for Deadly Surgery
Philadelphia injury attorney Leonard Hill, founder of Hill & Associates, P.C., represented the estate of Ellen Breen, who died following a minimally invasive surgery that went wrong. Hill's colleague Susan Ayres also assisted in representing the...

at 09:00
Recognize National Women's Health Week by Taking Care of Your Gut Microbiome With Gundry MD Total Restore
National Women's Health Week encourages women to prioritize their well-being through preventive care, healthy habits, and regular check-ups....

at 07:12
ZINZINO AB (PUBL): Zinzino acquires assets in Xeliss - strategic reinforcement in southern Europe and in the microalgae spirulina
Zinzino, the global health and wellness brand from Scandinavia, has acquired, through a business asset acquisition, the rights to the distributor database and associated customer register, inventory, and intellectual property of the Luxembourg-based...

at 05:53
Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Cevira in China
Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) communicated today that the National Medical Products Administration (NMPA) has accepted its new drug application (NDA) for the...

at 05:43
Second Opinion Expert Announces Strategic Relationship with KangarooHealth
SecondOpinionExpert, Inc. (SOE), a leading healthcare technology company, announced today that it has entered into a strategic relationship with KangarooHealth, Inc. to improve patient health outcomes, as well as reduce the cost of delivering care by...

11 mai 2024
Fast-Growing Prior Authorization Software Company Announces Addition of Chief Revenue Officer
eBlu Solutions, a leading provider of innovative technology solutions for the specialty healthcare industry, is pleased to announce the addition of Doug Lawrence to the Executive Leadership team in the role of Chief Revenue Officer. "We're not just...

More news about Health...


News published on and distributed by: